Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $34.5B |
| FY2017, ended Dec 31, 2017 | $52.6B |
| FY2018, ended Dec 31, 2018 | $57.5B |
| FY2019, ended Dec 31, 2019 | $75.9B |
| FY2020, ended Dec 31, 2020 | $677B |
| FY2021, ended Dec 31, 2021 | $1.09T |
| FY2022, ended Dec 31, 2022 | $390B |
| FY2023, ended Dec 31, 2023 | $791B |
| FY2024, ended Dec 31, 2024 | $1.30T |
| FY2025, ended Dec 31, 2025 | $1.69T |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $1.40T |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $7.00B |
| FY2017, ended Dec 31, 2017 | $11.8B |
| FY2018, ended Dec 31, 2018 | $21.5B |
| FY2019, ended Dec 31, 2019 | $24.6B |
| FY2020, ended Dec 31, 2020 | $31.5B |
| FY2021, ended Dec 31, 2021 | $53.8B |
| FY2022, ended Dec 31, 2022 | $81.5B |
| FY2023, ended Dec 31, 2023 | $96.8B |
| FY2024, ended Dec 31, 2024 | $97.7B |
| FY2025, ended Dec 31, 2025 | $94.8B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $104B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | −$675M | −$1.40B |
| FY2017, ended Dec 31, 2017 | −$1.96B | −$3.48B |
| FY2018, ended Dec 31, 2018 | −$976M | −$3.00M |
| FY2019, ended Dec 31, 2019 | −$862M | $1.08B |
| FY2020, ended Dec 31, 2020 | $721M | $2.79B |
| FY2021, ended Dec 31, 2021 | $5.52B | $5.01B |
| FY2022, ended Dec 31, 2022 | $12.6B | $7.57B |
| FY2023, ended Dec 31, 2023 | $15.0B | $4.36B |
| FY2024, ended Dec 31, 2024 | $7.09B | $3.58B |
| FY2025, ended Dec 31, 2025 | $3.79B | $6.22B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $3.22B | $3.30B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.39B |
| FY2017, ended Dec 31, 2017 | $3.37B |
| FY2018, ended Dec 31, 2018 | $3.69B |
| FY2019, ended Dec 31, 2019 | $6.27B |
| FY2020, ended Dec 31, 2020 | $19.4B |
| FY2021, ended Dec 31, 2021 | $17.6B |
| FY2022, ended Dec 31, 2022 | $16.3B |
| FY2023, ended Dec 31, 2023 | $16.4B |
| FY2024, ended Dec 31, 2024 | $16.1B |
| FY2025, ended Dec 31, 2025 | $16.5B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $17.9B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $6.02B |
| FY2017, ended Dec 31, 2017 | $8.83B |
| FY2018, ended Dec 31, 2018 | $8.41B |
| FY2019, ended Dec 31, 2019 | $10.4B |
| FY2020, ended Dec 31, 2020 | $8.46B |
| FY2021, ended Dec 31, 2021 | $4.25B |
| FY2022, ended Dec 31, 2022 | $1.03B |
| FY2023, ended Dec 31, 2023 | $2.68B |
| FY2024, ended Dec 31, 2024 | $5.54B |
| FY2025, ended Dec 31, 2025 | $6.58B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $7.96B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 63.0% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 2.43B |
| FY2017, ended Dec 31, 2017 | 2.53B |
| FY2018, ended Dec 31, 2018 | 2.59B |
| FY2019, ended Dec 31, 2019 | 2.72B |
| FY2020, ended Dec 31, 2020 | 2.88B |
| FY2021, ended Dec 31, 2021 | 3.10B |
| FY2022, ended Dec 31, 2022 | 3.16B |
| FY2023, ended Dec 31, 2023 | 3.18B |
| FY2024, ended Dec 31, 2024 | 3.22B |
| FY2025, ended Dec 31, 2025 | 3.75B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 3.95B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Paid to employees | Sold for cash | Used in acquisitions |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $334M | $1.70B | $2.15B |
| FY2017, ended Dec 31, 2017 | $467M | $400M | $269M |
| FY2018, ended Dec 31, 2018 | $749M | — | — |
| FY2019, ended Dec 31, 2019 | $898M | $848M | $482M |
| FY2020, ended Dec 31, 2020 | $1.73B | $12.3B | — |
| FY2021, ended Dec 31, 2021 | $2.12B | $0 | — |
| FY2022, ended Dec 31, 2022 | $1.56B | $0 | — |
| FY2023, ended Dec 31, 2023 | $1.81B | — | — |
| FY2024, ended Dec 31, 2024 | $2.00B | — | — |
| FY2025, ended Dec 31, 2025 | $2.83B | — | — |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $4.30B | — | — |
Valuation
At current price- Market Cap
- $1.61T
- P/E
- 500×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 15.6×
- Price / Book
- 18.0×
- EV / EBITDA
- 175×
Growth
Trailing 12 months- Revenue (TTM)
- $104B
- Revenue Growth YoY
- 8.3%
- Revenue CAGR 3Y
- 5.2%
- Revenue CAGR 5Y
- 24.6%
- EPS Growth YoY
- −37.2%
- Net Income Growth YoY
- −36.7%
Profitability
Trailing 12 months- Gross Margin
- 19.3%
- Operating Margin
- 3.3%
- Net Margin
- 3.1%
- FCF Margin
- 3.2%
- Return on Equity
- 3.8%
Earnings
Trailing 12 months- Net Income
- $3.22B
- EPS (diluted)
- $0.91
- EBITDA
- $9.14B
- Operating Income
- $3.47B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $17.9B
- Total Debt
- $7.96B
- Net Cash
- $9.90B
- Total Assets
- $158B
- Total Liabilities
- $67.6B
- Shareholders' Equity
- $89.3B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $18.7B
- Capital Expenditure
- $15.4B
- Free Cash Flow
- $3.30B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 1.90
Every ratio is calculated from the company’s reported figures.